GlassScriptPhysician profile
Charles Peyton Colvin
NPI 1811906126
$3,479.51
in general payments reported to CMS, 2019-2025
22 companies · $790 in 2025
The $790 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $374 · 2020: $70.05 · 2021: $394 · 2022: $645 · 2023: $415 · 2024: $790 · 2025: $790.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,995.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,995.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $626.42 | 2019-2025 | Dupixent |
| Genzyme Corporation | $522.93 | 2023-2025 | |
| Optinose US, INC. | $468.82 | 2019-2024 | |
| Inspire Medical Systems, INC. | $463.59 | 2021-2025 | Inspire |
| Glaxosmithkline, LLC. | $441.42 | 2021-2025 | Nucala |
| Intersect Ent, INC. | $268.23 | 2019-2022 | |
| Medtronic, INC. | $133.05 | 2022-2024 | Stealthstation S8 Platform |
| Aroa Biosurgery Incorporated | $125.38 | 2022-2024 | |
| Janssen Biotech, INC. | $84.50 | 2022 | |
| Integra Lifesciences Corporation | $54.66 | 2022-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Stryker Corporation | $51.77 | 2019-2021 | |
| Cook Medical LLC | $32.60 | 2019-2020 | |
| Smith+Nephew, INC. | $29.51 | 2024 | Halo, Tula |
| Olympus America INC. | $26.58 | 2019 | |
| Amgen INC. | $25.39 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $21.56 | 2024 | |
| Hologic Sales and Service, LLC | $19.22 | 2022 | |
| Novartis Pharmaceuticals Corporation | $18.90 | 2019 | |
| Phadia US INC. | $18.66 | 2023 | Immunocap |
| Abbvie INC. | $16.75 | 2025 | |
| Arbor Pharmaceuticals, INC. | $15.82 | 2019 | |
| Paratek Pharmaceuticals, INC. | $13.75 | 2025 | Xhance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Colvin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.